CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Eye Health (703)
Oculis is a Lausanne, Switzerland-based clinical-stage biopharmaceutical company developing topical ophthalmic treatments for ophthalmic diseases for both back- and front-of-the-eye in order to improve the sight and lives of patients worldwide.
Company (Alive / Active)
Phone: +41 21 711 3970
EPFL Innovation Park
Building C
Lausanne, 1015
Switzerland
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Cyclodextrin nanotechnology for ophthalmic drug delivery | Dec 13, 2013 | Apr 07, 2015 | Patent |
| Cyclodextrin nanotechnology for ophthalmic drug delivery | Feb 04, 2013 | Jan 21, 2014 | Patent |
| Cyclodextrin nanotechnology for ophthalmic drug delivery | Jul 20, 2006 | Feb 22, 2011 | Patent |
| Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery | Nov 29, 2017 | Application | |
| Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery | Nov 29, 2017 | Application |
